Finnish biotech scaleup Enifer is the first Nordic company to apply for Novel Food approval for a mycoprotein ingredient. With its new production facility, set to be completed in 2025, Enifer will produce 3,000 tons of mycoprotein annually.
Read more
Earlier this year, Enifer announced that their first €33M PEKILO® factory is fully funded and will be built in Kantvik, Finland. Now, the time has come to turn vision into reality, as construction kicks with demolition and procurement.
Read more
“We are very happy to start cooperation with Enifer. We believe that there is an increased need for alternative proteins as the global population grows. Demand is also supported globally by environmental and ethical considerations. Taaleri Bioindustry Fund I’s investment enables commercial scale production. We are confident in Enifer’s opportunities to expand,” comments Tero Saarno, Managing Director, Taaleri Bioindustry.
Read more
Business Finland has conditionally approved a recycling and reuse investment grant of more than €12 million for biotech startup Enifer to build its first commercial-scale PEKILO® mycoprotein ingredient factory.
Read more
Valio and Enifer are joining forces to create a new, future-proof product for the plant-based protein field. Originally invented in the 1970s, PEKILO® has been further developed by Enifer and is now ready to scale.
Read more
Finnish biotech scaleup Enifer is the first Nordic company to apply for Novel Food approval for a mycoprotein ingredient. With its new production facility, set to be completed in 2025, Enifer will produce 3,000 tons of mycoprotein annually.
Read more
Read more
“We are very happy to start cooperation with Enifer. We believe that there is an increased need for alternative proteins as the global population grows. Demand is also supported globally by environmental and ethical considerations. Taaleri Bioindustry Fund I’s investment enables commercial scale production. We are confident in Enifer’s opportunities to expand,” comments Tero Saarno, Managing Director, Taaleri Bioindustry.
Read more
Global shrimp farmers face challenges with soaring costs and rampaging diseases that diminish their profits. A new study conducted by AquaBioTech shows that shrimps fed with Enifer’s PEKILO®Aqua mycoprotein lived longer and healthier despite their natural proneness to diseases.
Read more
Business Finland has conditionally approved a recycling and reuse investment grant of more than €12 million for biotech startup Enifer to build its first commercial-scale PEKILO® mycoprotein ingredient factory.
Read more
With the investment, Enifer will begin to scale the production of its proprietary PEKILO® mycoprotein powder - a sustainable and locally produced alternative protein containing very high levels of protein.
Read more
The partnership between Enifer and Skretting has been strengthened by the signing of an agreement that defines the future steps for testing PEKILO® protein in Atlantic salmon and rainbow trout.
Read more
Valio and Enifer are joining forces to create a new, future-proof product for the plant-based protein field. Originally invented in the 1970s, PEKILO® has been further developed by Enifer and is now ready to scale.
Read more
Read more
Read more
Supported by a €1.2M BlueInvest Grant, AquaPekilo project’s overall objective is to bring to market a novel, cost-competitive, locally produced, and sustainable aquaculture feed protein ingredient for use as an alternative to soy.
Read more
